Mark Holodniy
Publication Details
-
New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis.
Ann Intern Med. 2012; (4): 279-90
Chronic hepatitis C virus is difficult to treat and affects approximately 3 million Americans. Protease inhibitors increase the effectiveness of standard therapy, but they are costly. A genetic assay may identify patients most likely to benefit from this treatment advance.
Help